Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.
about
Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.Genetic variation at the CYP2C19 gene associated with metabolic syndrome susceptibility in a South Portuguese population: results from the pilot study of the European Health Examination Survey in Portugal.Pharmacogenetics guided anticoagulation.TRITON and beyond: new insights into the profile of prasugrel.Gender and anti-thrombotic therapy: from biology to clinical implications.Routine genotyping of patients on clopidogrel: Why the resistance?Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?
P2860
Q34131354-95404F52-AA57-4092-8B98-B07F118421E9Q37599633-751B6FE6-9BDC-4480-867A-D2465ECFDED8Q37808224-2737C794-FB3E-49A2-BA52-82F70B3CDA7CQ37925009-2F0F5599-399C-4BF5-9AA2-7519CFAAC188Q38182428-5E2648DA-AA4C-4ECB-AA5F-9661A5238B48Q42414159-6912B763-71B5-489A-9293-29D38A33FEAAQ42731695-5A61D023-15BF-4700-B06F-023DD73C2141
P2860
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.
@en
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.
@nl
type
label
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.
@en
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.
@nl
prefLabel
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.
@en
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.
@nl
P2860
P50
P1476
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis
@en
P2093
Rosanna Abbate
P2860
P304
P356
10.1517/17425251003598878
P407
P577
2010-04-01T00:00:00Z